Related Experiment Videos
[HLA antigens in bipolar affective patients]
Actas Luso-Espanolas De Neurologia, Psiquiatria Y Ciencias Afines
|September 1, 1990
Summary
Human Leukocyte Antigen (HLA) antigens A29 and B21 were more frequent in bipolar disorder patients. Certain HLA antigens may also correlate with non-response to lithium treatment in these patients.
Area of Science:
- Immunogenetics
- Psychiatry
Context:
- Bipolar disorder is a complex mental health condition with a suspected genetic component.
- Human Leukocyte Antigen (HLA) systems are crucial for immune response and have been investigated for associations with various diseases.
Purpose:
- To investigate the prevalence of specific Human Leukocyte Antigen (HLA) antigens in patients diagnosed with bipolar affective disorder.
- To compare HLA antigen frequencies in bipolar patients with the general population and explore potential links to lithium treatment response.
Summary:
- A study analyzed HLA antigens in 36 bipolar disorder patients meeting DSM-III and RDC criteria using the Lymphotoxicity Test.
- Results indicated a statistically significant higher frequency of A29 and B21 HLA antigens in bipolar patients compared to controls.
- The A2 HLA antigen was also observed more frequently in bipolar patients who did not respond to lithium treatment.
Impact:
- This research highlights potential immunogenetic markers associated with bipolar disorder.
- Findings may contribute to understanding the biological underpinnings of bipolar illness and treatment response.
- Further investigation is warranted to confirm these associations and mitigate the risk of false positives in genetic studies.